Shycocan

Bengaluru, India Founded: 2020 • Age: 6 yrs
Virus attenuation devices are developed for indoor coronavirus neutralization.
Annual revenue $177,313 Latest available
Total funding $2.5M 2 rounds
Employees 72 Tracked headcount
Investors 2 Known backers
Products 1 Services tracked
Competitors - Brand Intelligence

About Shycocan

Shycocan is a company based in Bengaluru (India) founded in 2020. Shycocan has raised $2.47 million across 2 funding rounds from investors including Exxora Trading and Exxora Trading. The company has 72 employees as of March 17, 2025. Shycocan offers products and services including Shycocan Device.

  • Headquarter Bengaluru, India
  • Employees 72 as on 17 Mar, 2025
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Shycocare Technologies Private Limited
  • Date of Incorporation 29 Jul, 2020
  • Jurisdiction Bangalore, Karnataka, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $177.31 K (USD)
    -94.81
    as on Mar 31, 2023
  • Net Profit
    -$1.24 M (USD)
    -165.59
    as on Mar 31, 2023
  • EBITDA
    -$1.37 M (USD)
    -123.48
    as on Mar 31, 2023
  • Total Equity Funding
    $2.47 M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.12 M (USD), Seed

    Mar 31, 2023

  • Investors
  • Employee Count
    72

    as on Mar 17, 2025

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Shycocan

Shycocan offers a comprehensive portfolio of products and services, including Shycocan Device.

Product name locked
Category locked
Primary

Neutralizes airborne viruses and bacteria for safer indoor air environments.

Funding Insights of Shycocan

Shycocan has successfully raised a total of $2.47M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.12 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Shycocan

Shycocan has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Exxora Trading and Exxora Trading.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity firm focused on multiple sectors
Locked Locked Locked
Venture capital fund focused on multiple sectors
Locked Locked Locked
Premium access

Investor details for Shycocan

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Shycocan

Investments
Premium access

Investment portfolio details for Shycocan

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Shycocan

Premium access

Detailed financials for Shycocan

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Shycocan Comparisons

Shycocan Primary company
Description
Virus attenuation devices are developed for indoor coronavir...
Location
Bengaluru, India
Founded Year
2020
Annual Revenue
$177.31 K (USD)
Net Profit
-$1.24 M (USD)
EBITDA
-$1.37 M (USD)
Employees
72
As of 2025
Premium access

Peer comparison for Shycocan

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Shycocan

Premium access

Detailed competitors of Shycocan

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Shycocan

Premium access

Complete news archive for Shycocan

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shycocan

Shycocan was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Shycocan is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Shycocan is a funded company, having raised a total of $2.47M across 2 funding rounds to date.

As of Mar 17, 2025, the latest employee count at Shycocan is 72.

Annual revenue of Shycocan is $177.31K as on Mar 31, 2023.

Shycocan was founded in 2020 in Bengaluru, India, focusing on health technology. A device is produced that emits photons to create a negatively charged electron cloud, which neutralizes the positive charge on the S-protein of coronaviruses. This technology is applied in various indoor environments to attenuate viral activity. Operations center on device development and deployment for public health applications.

Shycocan offers Shycocan Device.

Shycocan has 2 investors. Key investors include Exxora Trading, and Exxora Trading.

The valuation of Shycocan is $15.01M as of Mar 2023.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available